In Depth 30 Oct 2024
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.
- Latest Posts
Best in Biotech 29 Oct 2024
GPCR therapies: Eight promising biotechs hacking the cell signaling pathway
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.
In Depth 25 Oct 2024
How biotech startups are trying to save the oceans with lab-grown fish
Find out everything you need to know about lab-grown fish, including the startups trying to save the oceans with their products.
Podcast 25 Oct 2024
Biotech beyond earth: The future of medicine in space
LinkGevity was selected for a NASA program for its potential to minimize the health and performance risks in human spaceflight. Find out more!
News and Trends 24 Oct 2024
Fighting severe epilepsies: A new era for Dravet syndrome treatment?
Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.
Best in Biotech 24 Oct 2024
Six biotech companies advancing multiple sclerosis therapies
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 23 Oct 2024
RNA editing in humans: the race begins with first successful trial
Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space.
Best in Biotech 22 Oct 2024
Eight nanotechnology companies to watch out for
Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.
News and Trends 21 Oct 2024
Turning back time with cellular reprogramming: Shift raises $16 million in seed funding
As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.
In Depth 18 Oct 2024
The AI boom in cancer: Game-changer or just hype?
Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment.
Podcast 18 Oct 2024
The future of gene therapy
This week, we have a conversation with Michael Parini, CEO of Spur Therapeutics, about the future of gene therapy.
Best in Biotech 17 Oct 2024
Top six European biotech entrepreneurs to know in 2024 (according to VCs)
We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market.
ADVERTISEMENT
